Cumberland Pharmaceuticals Inc. (CPIX) vs Sofgen Pharma S.A (PROCF)
- Cumberland Pharmaceuticals Inc. CPIX 7.18 −4.77%
- Sofgen Pharma S.A PROCF 0.03 0.00%
Cumberland Pharmaceuticals Inc. and Sofgen Pharma S.A are both Drug Manufacturers Specialty & Generic companies. Cumberland Pharmaceuticals Inc. and Sofgen Pharma S.A are of similar size ($114.0M and $113.0M). Cumberland Pharmaceuticals Inc. has negative trailing earnings, so its P/E is not meaningful; Sofgen Pharma S.A trades at 0.1×. Cumberland Pharmaceuticals Inc. grew revenue faster over the last twelve months: 32.0% against 5.10%. Sofgen Pharma S.A has the higher net margin (9.52% vs −26.2%) and the higher return on invested capital (15.2% vs −34.2%). Across the 18 metrics below, Sofgen Pharma S.A leads on 12 and Cumberland Pharmaceuticals Inc. on 6.
Valuation
Profitability
| Metric | CPIX | PROCF | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 82.80% | 56.16% | 53.94% |
| Operating margin | (17.39%) | 17.01% | 0.00% |
| Net margin | (26.17%) | 9.52% | 0.00% |
| Free cash flow margin | 1.38% | 17.66% | 0.00% |
| Return on equity | (48.76%) | (213.06%) | (0.40%) |
| Return on assets | (16.70%) | 8.82% | (3.32%) |
| Return on invested capital | (34.23%) | 15.21% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack